Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

77 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.
Davidson M, Saoud J, Staner C, Noel N, Luthringer E, Werner S, Reilly J, Schaffhauser JY, Rabinowitz J, Weiser M, Luthringer R. Davidson M, et al. Among authors: luthringer r, luthringer e. Am J Psychiatry. 2017 Dec 1;174(12):1195-1202. doi: 10.1176/appi.ajp.2017.17010122. Epub 2017 Jul 28. Am J Psychiatry. 2017. PMID: 28750582 Clinical Trial.
77 results